A retrospective observational study of enuresis, daytime voiding symptoms, and response to medical therapy in children with attention deficit hyperactivity disorder and autism spectrum disorder
Abstract Introduction Children with attention deficit hyperactivity disorder (ADHD) show an increased prevalence of enuresis and other daytime voiding symptoms (DVS). There is also some evidence toward an increased prevalence of enuresis among children with autism spectrum disorder (ASD), but with n...
Gespeichert in:
Veröffentlicht in: | Journal of pediatric urology 2012-06, Vol.8 (3), p.314-317 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 317 |
---|---|
container_issue | 3 |
container_start_page | 314 |
container_title | Journal of pediatric urology |
container_volume | 8 |
creator | Gor, Ronak A Fuhrer, Jamie Schober, Justine M |
description | Abstract Introduction Children with attention deficit hyperactivity disorder (ADHD) show an increased prevalence of enuresis and other daytime voiding symptoms (DVS). There is also some evidence toward an increased prevalence of enuresis among children with autism spectrum disorder (ASD), but with no data available with respect to DVS or response to medical treatment. The aim of this study was to assess enuresis and DVS, along with treatment outcomes, in children with ASD, to aid urological management. Methods A retrospective observational study on the incidence of enuresis and other DVS in 671 children with/without ADHD/ASD was performed. Symptomatic improvement ≥50% was required to be considered positive. Complete resolution of symptoms for 3 months after cessation of treatment was considered cure. Results Symptomatic improvement with desmopressin or anticholinergic treatment was seen in 76% of patients without ADHD/ASD, 85% of patients with ADHD, and 100% of patients with ASD. Cure was seen in 61% of patients without ADHD/ASD, 48% of patients with ADHD, and 50% patients with ASD. Mean time to cure was 9 months in those without ADHD/ASD ( N = 319), 10 months in those with ADHD ( N = 62), and 8 months in those with ASD ( N = 10) ( P = 0.69). Conclusion Despite the small sample size of patients with ASD, our data show a favorable trend toward efficacy of desmopressin and anticholinergic therapy in these children with enuresis and DVS. |
doi_str_mv | 10.1016/j.jpurol.2010.10.009 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1013921710</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1477513110004870</els_id><sourcerecordid>1013921710</sourcerecordid><originalsourceid>FETCH-LOGICAL-c417t-b0affd9697547499de4d82a7fd88b070b705594cb0c2c37c00467713873085993</originalsourceid><addsrcrecordid>eNqFUk2P1DAMrRCIXRb-AUI5cqBD0nYmzQVptVo-pJU4AOcoTVzGQ5uUJB3Un8c_w51Z9sCFUyL7-dl-z0XxUvCN4GL39rA5THMMw6bip9CGc_WouBStrMumVe1j-jdSlltRi4viWUoHzmvJK_W0uKgEBau6uSx-X7MIOYY0gc14BBa6BPFoMgZvBpby7BYWegZ-jpAwvWHOLBlHYMeADv13lpZxymGkjPGOyNIUfAKWAxvBoSWSvIdopoWhZ3aPg4vg2S_Me2ZyBr92Yg56tJjZfpkIu06CeWEOU4gO4onZzBnTyE6Dxnl8SD4vnvRmSPDi_r0qvr2__Xrzsbz7_OHTzfVdaRshc9lx0_dO7ZTcNrJRykHj2srI3rVtxyXvJN9uVWM7bitbS8t5s5NS1CQnb7dK1VfF6zPvFMPPGVLWIyYLw2A8hDlpMqVWlZCCE7Q5Qy0JmyL0eoo4mrgQaMXt9EGfzdOreWuUzKOyV_cd5o60eyj66xYB3p0BQHseEaJOFsFb0jmSKtoF_F-HfwnsgH416QcskA5hjuQ67aJTpbn-sh7Qej-Ckxyt5PUfNVfHVg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1013921710</pqid></control><display><type>article</type><title>A retrospective observational study of enuresis, daytime voiding symptoms, and response to medical therapy in children with attention deficit hyperactivity disorder and autism spectrum disorder</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Gor, Ronak A ; Fuhrer, Jamie ; Schober, Justine M</creator><creatorcontrib>Gor, Ronak A ; Fuhrer, Jamie ; Schober, Justine M</creatorcontrib><description>Abstract Introduction Children with attention deficit hyperactivity disorder (ADHD) show an increased prevalence of enuresis and other daytime voiding symptoms (DVS). There is also some evidence toward an increased prevalence of enuresis among children with autism spectrum disorder (ASD), but with no data available with respect to DVS or response to medical treatment. The aim of this study was to assess enuresis and DVS, along with treatment outcomes, in children with ASD, to aid urological management. Methods A retrospective observational study on the incidence of enuresis and other DVS in 671 children with/without ADHD/ASD was performed. Symptomatic improvement ≥50% was required to be considered positive. Complete resolution of symptoms for 3 months after cessation of treatment was considered cure. Results Symptomatic improvement with desmopressin or anticholinergic treatment was seen in 76% of patients without ADHD/ASD, 85% of patients with ADHD, and 100% of patients with ASD. Cure was seen in 61% of patients without ADHD/ASD, 48% of patients with ADHD, and 50% patients with ASD. Mean time to cure was 9 months in those without ADHD/ASD ( N = 319), 10 months in those with ADHD ( N = 62), and 8 months in those with ASD ( N = 10) ( P = 0.69). Conclusion Despite the small sample size of patients with ASD, our data show a favorable trend toward efficacy of desmopressin and anticholinergic therapy in these children with enuresis and DVS.</description><identifier>ISSN: 1477-5131</identifier><identifier>EISSN: 1873-4898</identifier><identifier>DOI: 10.1016/j.jpurol.2010.10.009</identifier><identifier>PMID: 21131234</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Anticholinergic ; Antidiuretic Agents - therapeutic use ; Asperger ; Attention Deficit and Disruptive Behavior Disorders - complications ; Autism ; Child ; Child Development Disorders, Pervasive - complications ; Cholinergic Antagonists - therapeutic use ; DDAVP ; Deamino Arginine Vasopressin - therapeutic use ; Desmopressin ; Enuresis ; Enuresis - complications ; Enuresis - drug therapy ; Enuresis - epidemiology ; Female ; Follow-Up Studies ; Humans ; Incidence ; Male ; Oxybutynin ; Pediatrics ; Pennsylvania - epidemiology ; Pervasive developmental disorder ; Retrospective Studies ; Tolterodine ; Treatment Outcome ; Urination - drug effects ; Urination - physiology ; Urology ; Voiding dysfunction</subject><ispartof>Journal of pediatric urology, 2012-06, Vol.8 (3), p.314-317</ispartof><rights>Journal of Pediatric Urology Company</rights><rights>2010 Journal of Pediatric Urology Company</rights><rights>Copyright © 2010 Journal of Pediatric Urology Company. Published by Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c417t-b0affd9697547499de4d82a7fd88b070b705594cb0c2c37c00467713873085993</citedby><cites>FETCH-LOGICAL-c417t-b0affd9697547499de4d82a7fd88b070b705594cb0c2c37c00467713873085993</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jpurol.2010.10.009$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21131234$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gor, Ronak A</creatorcontrib><creatorcontrib>Fuhrer, Jamie</creatorcontrib><creatorcontrib>Schober, Justine M</creatorcontrib><title>A retrospective observational study of enuresis, daytime voiding symptoms, and response to medical therapy in children with attention deficit hyperactivity disorder and autism spectrum disorder</title><title>Journal of pediatric urology</title><addtitle>J Pediatr Urol</addtitle><description>Abstract Introduction Children with attention deficit hyperactivity disorder (ADHD) show an increased prevalence of enuresis and other daytime voiding symptoms (DVS). There is also some evidence toward an increased prevalence of enuresis among children with autism spectrum disorder (ASD), but with no data available with respect to DVS or response to medical treatment. The aim of this study was to assess enuresis and DVS, along with treatment outcomes, in children with ASD, to aid urological management. Methods A retrospective observational study on the incidence of enuresis and other DVS in 671 children with/without ADHD/ASD was performed. Symptomatic improvement ≥50% was required to be considered positive. Complete resolution of symptoms for 3 months after cessation of treatment was considered cure. Results Symptomatic improvement with desmopressin or anticholinergic treatment was seen in 76% of patients without ADHD/ASD, 85% of patients with ADHD, and 100% of patients with ASD. Cure was seen in 61% of patients without ADHD/ASD, 48% of patients with ADHD, and 50% patients with ASD. Mean time to cure was 9 months in those without ADHD/ASD ( N = 319), 10 months in those with ADHD ( N = 62), and 8 months in those with ASD ( N = 10) ( P = 0.69). Conclusion Despite the small sample size of patients with ASD, our data show a favorable trend toward efficacy of desmopressin and anticholinergic therapy in these children with enuresis and DVS.</description><subject>Anticholinergic</subject><subject>Antidiuretic Agents - therapeutic use</subject><subject>Asperger</subject><subject>Attention Deficit and Disruptive Behavior Disorders - complications</subject><subject>Autism</subject><subject>Child</subject><subject>Child Development Disorders, Pervasive - complications</subject><subject>Cholinergic Antagonists - therapeutic use</subject><subject>DDAVP</subject><subject>Deamino Arginine Vasopressin - therapeutic use</subject><subject>Desmopressin</subject><subject>Enuresis</subject><subject>Enuresis - complications</subject><subject>Enuresis - drug therapy</subject><subject>Enuresis - epidemiology</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Incidence</subject><subject>Male</subject><subject>Oxybutynin</subject><subject>Pediatrics</subject><subject>Pennsylvania - epidemiology</subject><subject>Pervasive developmental disorder</subject><subject>Retrospective Studies</subject><subject>Tolterodine</subject><subject>Treatment Outcome</subject><subject>Urination - drug effects</subject><subject>Urination - physiology</subject><subject>Urology</subject><subject>Voiding dysfunction</subject><issn>1477-5131</issn><issn>1873-4898</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFUk2P1DAMrRCIXRb-AUI5cqBD0nYmzQVptVo-pJU4AOcoTVzGQ5uUJB3Un8c_w51Z9sCFUyL7-dl-z0XxUvCN4GL39rA5THMMw6bip9CGc_WouBStrMumVe1j-jdSlltRi4viWUoHzmvJK_W0uKgEBau6uSx-X7MIOYY0gc14BBa6BPFoMgZvBpby7BYWegZ-jpAwvWHOLBlHYMeADv13lpZxymGkjPGOyNIUfAKWAxvBoSWSvIdopoWhZ3aPg4vg2S_Me2ZyBr92Yg56tJjZfpkIu06CeWEOU4gO4onZzBnTyE6Dxnl8SD4vnvRmSPDi_r0qvr2__Xrzsbz7_OHTzfVdaRshc9lx0_dO7ZTcNrJRykHj2srI3rVtxyXvJN9uVWM7bitbS8t5s5NS1CQnb7dK1VfF6zPvFMPPGVLWIyYLw2A8hDlpMqVWlZCCE7Q5Qy0JmyL0eoo4mrgQaMXt9EGfzdOreWuUzKOyV_cd5o60eyj66xYB3p0BQHseEaJOFsFb0jmSKtoF_F-HfwnsgH416QcskA5hjuQ67aJTpbn-sh7Qej-Ckxyt5PUfNVfHVg</recordid><startdate>20120601</startdate><enddate>20120601</enddate><creator>Gor, Ronak A</creator><creator>Fuhrer, Jamie</creator><creator>Schober, Justine M</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20120601</creationdate><title>A retrospective observational study of enuresis, daytime voiding symptoms, and response to medical therapy in children with attention deficit hyperactivity disorder and autism spectrum disorder</title><author>Gor, Ronak A ; Fuhrer, Jamie ; Schober, Justine M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c417t-b0affd9697547499de4d82a7fd88b070b705594cb0c2c37c00467713873085993</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Anticholinergic</topic><topic>Antidiuretic Agents - therapeutic use</topic><topic>Asperger</topic><topic>Attention Deficit and Disruptive Behavior Disorders - complications</topic><topic>Autism</topic><topic>Child</topic><topic>Child Development Disorders, Pervasive - complications</topic><topic>Cholinergic Antagonists - therapeutic use</topic><topic>DDAVP</topic><topic>Deamino Arginine Vasopressin - therapeutic use</topic><topic>Desmopressin</topic><topic>Enuresis</topic><topic>Enuresis - complications</topic><topic>Enuresis - drug therapy</topic><topic>Enuresis - epidemiology</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Incidence</topic><topic>Male</topic><topic>Oxybutynin</topic><topic>Pediatrics</topic><topic>Pennsylvania - epidemiology</topic><topic>Pervasive developmental disorder</topic><topic>Retrospective Studies</topic><topic>Tolterodine</topic><topic>Treatment Outcome</topic><topic>Urination - drug effects</topic><topic>Urination - physiology</topic><topic>Urology</topic><topic>Voiding dysfunction</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gor, Ronak A</creatorcontrib><creatorcontrib>Fuhrer, Jamie</creatorcontrib><creatorcontrib>Schober, Justine M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of pediatric urology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gor, Ronak A</au><au>Fuhrer, Jamie</au><au>Schober, Justine M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A retrospective observational study of enuresis, daytime voiding symptoms, and response to medical therapy in children with attention deficit hyperactivity disorder and autism spectrum disorder</atitle><jtitle>Journal of pediatric urology</jtitle><addtitle>J Pediatr Urol</addtitle><date>2012-06-01</date><risdate>2012</risdate><volume>8</volume><issue>3</issue><spage>314</spage><epage>317</epage><pages>314-317</pages><issn>1477-5131</issn><eissn>1873-4898</eissn><abstract>Abstract Introduction Children with attention deficit hyperactivity disorder (ADHD) show an increased prevalence of enuresis and other daytime voiding symptoms (DVS). There is also some evidence toward an increased prevalence of enuresis among children with autism spectrum disorder (ASD), but with no data available with respect to DVS or response to medical treatment. The aim of this study was to assess enuresis and DVS, along with treatment outcomes, in children with ASD, to aid urological management. Methods A retrospective observational study on the incidence of enuresis and other DVS in 671 children with/without ADHD/ASD was performed. Symptomatic improvement ≥50% was required to be considered positive. Complete resolution of symptoms for 3 months after cessation of treatment was considered cure. Results Symptomatic improvement with desmopressin or anticholinergic treatment was seen in 76% of patients without ADHD/ASD, 85% of patients with ADHD, and 100% of patients with ASD. Cure was seen in 61% of patients without ADHD/ASD, 48% of patients with ADHD, and 50% patients with ASD. Mean time to cure was 9 months in those without ADHD/ASD ( N = 319), 10 months in those with ADHD ( N = 62), and 8 months in those with ASD ( N = 10) ( P = 0.69). Conclusion Despite the small sample size of patients with ASD, our data show a favorable trend toward efficacy of desmopressin and anticholinergic therapy in these children with enuresis and DVS.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>21131234</pmid><doi>10.1016/j.jpurol.2010.10.009</doi><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1477-5131 |
ispartof | Journal of pediatric urology, 2012-06, Vol.8 (3), p.314-317 |
issn | 1477-5131 1873-4898 |
language | eng |
recordid | cdi_proquest_miscellaneous_1013921710 |
source | MEDLINE; Access via ScienceDirect (Elsevier) |
subjects | Anticholinergic Antidiuretic Agents - therapeutic use Asperger Attention Deficit and Disruptive Behavior Disorders - complications Autism Child Child Development Disorders, Pervasive - complications Cholinergic Antagonists - therapeutic use DDAVP Deamino Arginine Vasopressin - therapeutic use Desmopressin Enuresis Enuresis - complications Enuresis - drug therapy Enuresis - epidemiology Female Follow-Up Studies Humans Incidence Male Oxybutynin Pediatrics Pennsylvania - epidemiology Pervasive developmental disorder Retrospective Studies Tolterodine Treatment Outcome Urination - drug effects Urination - physiology Urology Voiding dysfunction |
title | A retrospective observational study of enuresis, daytime voiding symptoms, and response to medical therapy in children with attention deficit hyperactivity disorder and autism spectrum disorder |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T05%3A02%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20retrospective%20observational%20study%20of%20enuresis,%20daytime%20voiding%20symptoms,%20and%20response%20to%20medical%20therapy%20in%20children%20with%20attention%20deficit%20hyperactivity%20disorder%20and%20autism%20spectrum%20disorder&rft.jtitle=Journal%20of%20pediatric%20urology&rft.au=Gor,%20Ronak%20A&rft.date=2012-06-01&rft.volume=8&rft.issue=3&rft.spage=314&rft.epage=317&rft.pages=314-317&rft.issn=1477-5131&rft.eissn=1873-4898&rft_id=info:doi/10.1016/j.jpurol.2010.10.009&rft_dat=%3Cproquest_cross%3E1013921710%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1013921710&rft_id=info:pmid/21131234&rft_els_id=1_s2_0_S1477513110004870&rfr_iscdi=true |